BioPharma Resources

Drug Trial Radar · NCT07416474

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Randomized, Double-Blind, Multicenter Phase III Study of RC148 in Combination With Platinum-Based Chemotherapy Versus Tislelizumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

Last checked: Nov 19, 2026Latest source record: Jul 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 574 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

574

Planned (sponsor's estimate)

Start

Apr 3, 2026

Primary completion

Dec 31, 2027

Study completion Nov 30, 2029

Sponsor

Lead sponsor
RemeGen Co., Ltd.Industry
Sponsor type
Industry
First posted
Feb 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to evaluate the efficacy and safety of RC148 combined with platinum-based chemotherapy versus Tislelizumab combined with platinum-based chemotherapy in participants with locally advanced or metastatic Squamous NSCLC who have not received first-line treatment. Participants will: Take RC148 or Tislelizumab combined with platinum-based chemotherapy until the end of the research.

Conditions

  • Non-Small Cell Lung Cancer

Interventions

  • RC148 plus Carboplatin and PaclitaxelDrug

    RC148, Carboplatin, Paclitaxel

  • Tislelizumab plus Carboplatin and PaclitaxelDrug

    Tislelizumab, Carboplatin, Paclitaxel

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS)Time frame: 24 months

Locations

78 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated Hospital of Hebei University

    Baoding, China · Recruiting

  • Peking Union Medical College Hospital

    Beijing, China · Recruiting

  • The First People's Hospital of Chenzhou City

    Binzhou, China · Recruiting

  • Cangzhou Central Hospital

    Cangzhou, China · Recruiting

  • Xiangya Hospital of Central South University

    Changsha, China · Recruiting

  • The Second Affiliated Hospital of Army Medical University of the Chinese People's Liberation Army

    Chongqing, China · Recruiting

  • Shanghai Chest Hospital

    Shanghai, China · Recruiting

  • Shanghai Pulmonary Hospital

    Shanghai, China · Recruiting

  • The First Hospital of Shanxi Medical University

    Taiyuan, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, China · Recruiting

  • Hubei Cancer Hospital

    Wuhan, China · Recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technolo

    Wuhan, China · Recruiting

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, China · Recruiting

  • Zhuzhou Central Hospital

    Zhuzhou, China · Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Peking University Cancer Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Cancer Hospital Affiliated to Chongqing University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Chongqing Medical University First Affiliated Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China · Recruiting

  • Union Hospital Affiliated to Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • The First Affiliated Hospital of Lanzhou University

    Lanzhou, Gansu, China · Recruiting

  • Dongguan People's Hospital

    Dongguan, Guangdong, China · Recruiting

  • Cancer Hospital Affiliated to Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen University First Affiliated Hospital

    Guangzhou, Guangdong, China · Recruiting

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Jiangmen Central Hospital

    Jiangmen, Guangdong, China · Recruiting

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The Fifth Affiliated Hospital of Sun Yat-sen University

    Zhuhai, Guangdong, China · Recruiting

  • The Second Affiliated Hospital of Guilin Medical University

    Guilin, Guangxi, China · Recruiting

  • Cancer Hospital Affiliated to Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

  • The First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangzhou, China · Recruiting

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China · Recruiting

  • The Fourth Affiliated Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • Cancer Hospital Affiliated to Harbin Medical University

    Harbin, Heilongjiang, China · Recruiting

  • Anyang Cancer Hospital

    Anyang, Henan, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.